personalized neoantigen peptide-based vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for personalized neoantigen peptide-based vaccine, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors [Phase 1, Phase 2]